 HEIDELBERG, Germany, Oct. 29, 2021 GLOBE NEWSWIRE -- Affimed N.V. Nasdaq: AFMD, a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that it will release third quarter 2021 results on Wednesday, November 10, 2021, and host a conference call at 8:30 a.m. EST to discuss financial results and recent corporate developments. 